Fig. 4From: Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinomaThe different IHC scores for the various protein types, CD44 (a), CD44v6 (b), CD44v8-10 (c), CD133 (d), EpCAM (e), and ALDH1A1 (f) according to tumor stagingBack to article page